Abstract:Objective To evaluate the effectiveness and safety of combination chemotherapy with bleomycin,etoposide and cisplatin (BEP) regimen on the patients with high-risk gestational trophoblastic neoplasia (GTN).Methods Forty-two patients with high-risk GTN admitted in Sichuan Cancer Hospital between Jan.1997 and Oct.2011 were analyzed retrospectively.The International Federation of Gynecology and Obstetrics (FIGO) prognostic score of all patients was more than 7.The mean age of patients was 30.2years (range 20 -49 years).All patients were treated with more than two cycles BEP regimen and followed up to the patients' death or at the end of Feb.2012.The clinical response,toxicity and the occurrence of secondary tumors were investigated.Results Forty-two high-risk GTN patients received the total of 251courses of the BEP regimen,the average number of courses for each patient was 6.0 courses.Thirty-seven patients achieved complete remission and 5 patients showed drug-resistant.The total complete remission rate of BEP regimen was 88％ ( 37/42 ).Among the complete remission patients,the total courses of BEP regimen of cases getting normal serum β-hCG level was 129 courses ( average 3.5 courses),and the total courses of cases achieving complete remission was 227 courses (average 6.1 courses ).Among the 37 complete remission patients,31 cases were treated with BEP regimen chemotherapy alone,4 patients with BEP regimen chemotherapy combined with surgical treatment (1 case had no cancer after surgery) and 2 cases with BEP regimen chemotherapy combined with radiation therapy.Therefore,the complete remission rate of BEP regimen chemotherapy alone was 74％ (31/42 ).There were 5 patients who showed drug-resistance after 24 courses of BEP regimen chemotherapy (average 4.8 courses),then received etoposide,methotrexate and dactinomycin( EMA )/cyclophosphamide and vincristine sulfate ( CO ) regimen chemotherapy after drugresistance,2 cases combined with radiation therapy,1 case combined with surgical treatment.Ultimately,4cases achieved complete remission,1 case died of cancer.The major toxicities of BEP regimen were included bone marrow suppression,digestive tract side effect and alopecic,followed by mild peripheral neuritis and abnormal liver function,rare cases of mild pulmonary toxicity.There were no severe anaphylaxis and obvious impairment of cardiac,liver,pulmonary and kidney function,except 1 patient (49 years old) had grade Ⅳbone marrow suppression and pulmonary fibrosis worsened after chemotherapy.The bone marrow suppression was mainly Ⅰ - Ⅲ degree neutropenia,and Incidence rate was 66.5％ ( 167/251 ).All the survival patients without secondary tumor.Conclusion For young high-risk GTN patients,BEP regimen chemotherapy may be safe and effective.

Combination chemotherapy of blemycin, etoposide, cisplatin or carboplatin for the treatment of malignant gestational trophoblastic tumor

Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia

BEP for High-Risk Gestational Trophoblastic Tumor: Results from a Cohort of 45 Patients.

[Combination Chemotherapy with Etoposide and Cisplatin for High-Risk, Chemorefractory and Recurrent Gestational Trophoblastic Neoplasia].

Clinical analysis of recurrent gestational trophoblastic neoplasia

Relapsed or Refractory Gestational Trophoblastic Neoplasia Treated with the Etoposide and Cisplatin/etoposide, Methotrexate, and Actinomycin D (EP‐EMA) Regimen

Combination Chemotherapy with 5-Fluorouracil, Methotrexate and Etoposide for Patients with High-Risk Gestational Trophoblastic Tumors: a Report Based on Our 11-Year Clinical Experiences.

Ema-Co Chemotherapy for High-Risk Gestational Trophoblastic Neoplasia: A Clinical Analysis of 54 Patients

[Single Methotrexate Chemotherapy for Low-Risk Gestational Trophoblastic Tumor].

[Curative Effects and Influenced Factors of Primary Chemotherapy with Single-Agent Methotrexate on Low-Risk Gestational Trophoblastic Neoplasia].

[Effects of Primary Chemotherapy with Single Methotrexate on Low-Risk Gestational Trophoblastic Neoplasia and Influencing Factors Thereof].

Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study

Combination Chemotherapy for High-Risk Gestational Trophoblastic Tumour.

Comparison of Tropisetron Versus Tropisetron Plus Methylprednisolone in Prevention of Chemotherapy Induced Emesis

5-Fu、MTX、VP16-213 Regime in the treatment of gestational trophoblastic tumor

Peba Regimen (Cisplatin, Etoposide, Bleomycin, And Adriamycin) In The Treatment Of Drug-Resistant Choriocarcinoma

Analysis on the clinical efficacy of 180 cases with gestational trophoblastic tumor

Diagnosis and management of or recurrent resistant gestational trophoblastic neoplasia

Intravenous-intraabdominal Combined Chemotherapy in Gestational Trophoblastic Tumor

The 16-Year Experience in Treating Low-Risk Gestational Trophoblastic Neoplasia Patients with Failed Primary Methotrexate Chemotherapy

Therapy for Refractory and Recurrent Gestational Trophoblastic Tumor